does medicaid cover glp 1 drugs GLP-1s prescriptions for weight loss are skyrocketing in North Carolina Medicaid Coverage of and Spending

Explore BPS Biosciences solutions for GLP-1R research in diabetes

You can wear multiple PatchAid patches at the same time

Emerging applications include non-alcoholic fatty liver disease and neurodegenerative conditions

Discussing Pfizer's savvy acquisition of Metsera and critiquing the GLP-1 'gap analysis' many outsiders promote as a reason all the Big Pharmas will be in GLP-1

Exposures Two cohorts were assembled, with the first composed of patients who started and continued on GLP-1 receptor agonists or DPP-4 inhibitors between 1 January 2007 and 31 December 2020 and the second composed of patients who started and continued on GLP-1 receptor agonists or SGLT-2 inhibitors between 1 January 1 2013 and 31 December 2020

Purpose Chronic kidney disease (CKD) is one of the most common complications of type 2 diabetes (T2D), and CKD-related disability and mortality are increasing despite the recent advances in diabetes management